Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07324733
NA

Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

Primary Sjögren's syndrome (pSS) is a chronic autoimmune exocrinopathy characterized by lymphocytic infiltration, progressive destruction of salivary gland acini, and varying degrees of functional impairment and fibrosis. Conventional imaging provides limited ability to simultaneously evaluate glandular function and inflammatory activity, leading to challenges in disease staging and treatment decision-making. This study explores a conceptual dual-tracer imaging framework using PSMA PET and FAPI PET to delineate complementary biological processes in pSS.

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-09-01

Completion Date

2026-05-30

Last Updated

2026-01-07

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

⁶⁸Ga-PSMA PET/CT

PSMA PET imaging performed for clinical evaluation in prostate cancer patients, used as a comparator for physiologic salivary gland PSMA uptake.

DIAGNOSTIC_TEST

⁶⁸Ga-FAPI PET/CT

FAPI PET imaging to assess inflammatory activity (FAPI) in patients with primary Sjögren's syndrome.

Locations (1)

Peking Union Medical College Hospital

Beijing, China